To determine whether PI3K pathway activity is necessary for the tumor- suppressing effect of the ESCMe, we treated the co-cultures with the PI3K agonist, VO-OHpic (VO), to stimulate the PI3K signaling (Figure 4C- D). Here, PIK3CG is linked to neoplasm.